Welcome to the international HTA database

Showing [16395 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Ranibizumab (Lucentis) for diabetic macular oedema
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chiropractic interventions for acute or chronic lower back pain in adults: a review of the clinical and cost-effectiveness
2009	NIHR Health Technology Assessment programme	Rimonabant for the treatment of overweight and obese people
2009	NIHR Health Technology Assessment programme	Non-occupational post-exposure prophylaxis for HIV
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Retigabine for partial onset epilepsy - refractory
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Alvimopan for surgical patients: a review of the clinical and cost-effectiveness
2009	NIHR Health Technology Assessment programme	Infliximab for the treatment of ulcerative colitis
2009	NIHR Health Technology Assessment programme	The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Sativex for adults experiencing pain from cancer
2009	NIHR Health Technology Assessment programme	Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2009	NIHR Health Technology Assessment programme	Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal
2009	HAYES, Inc.	Saw palmetto for benign prostatic hyperplasia
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Afamelanotide for erythropoietic protoporphyria and congenital erythropoietic porphyria
2009	NIHR Health Technology Assessment programme	A systematic review of presumed consent systems for deceased organ donation
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Alipogene tiparvovec (AMT-011, Glybera) for lipoprotein lipase deficiency
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Clopidogrel (Plavix) for neonates and infants with cyanotic congenital heart disease who have undergone a palliative shunt procedure
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Ofatumumab for fludarabine-refractory chronic lymphocytic leukaemia - second or third-line
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Omalizumab (Xolair) for severe persistent allergic asthma in children
2009	University of York	A systematic review of risk prediction rules in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Silodosin for benign prostatic hyperplasia
2009	HAYES, Inc.	Spinal cord stimulation for relief of neuropathic pain
2009	Medical Advisory Secretariat (MAS)	Specialized multidisciplinary community-based care series: summary of evidence-based analyses
2009	HAYES, Inc.	Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2009	NIHR Horizon Scanning Centre (NIHR HSC)	WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2009	Medical Advisory Secretariat (MAS)	Diabetes strategy evidence platform: summary of evidence-based analyses
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Agento I.C for ventilator associated pneumonia
2009	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Fast-track surgery and enhanced recovery after surgery (ERAS) programs
2009	Medical Advisory Secretariat (MAS)	Prevention and management of pressure ulcers: summary of evidence-based analyses
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Radachlorin photodynamic therapy for basal cell carcinoma
2009	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Endoscopic thoracic sympathectomy
2009	Medical Advisory Secretariat (MAS)	Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis
2009	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Neoadjuvant radiochemotherapy for rectal cancer
2009	Medical Advisory Secretariat (MAS)	Phakic intraocular lenses for the treatment of low to high refractive errors: an evidence-based analysis
2009	Belgian Health Care Knowledge Centre (KCE)	Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: Rapid assessment
2009	Medical Advisory Secretariat (MAS)	Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2009	Medical Advisory Secretariat (MAS)	Point-of-care international normalized ratio (INR) monitoring devices for patients on long-term oral anticoagulation therapy: an evidence-based analysis
2009	Medical Advisory Secretariat (MAS)	Oral appliances for obstructive sleep apnea: an evidence-based analysis
2009	NIHR Health Technology Assessment programme	Adalimumab for the treatment of moderate to severe psoriatic arthritis
2009	Medical Advisory Secretariat (MAS)	Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis
2009	Medical Advisory Secretariat (MAS)	OHTAC 2009 Progress Report - advancing health: evidence-based advice on health technology
2009	Medical Advisory Secretariat (MAS)	Intrastromal corneal ring implants for corneal thinning disorders: an evidence-based analysis
2009	Quality Improvement Scotland (NHS QIS )	Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective?
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Early term induction of labor
2009	Quality Improvement Scotland (NHS QIS )	Provision of information to patients with long term conditions
2009	Quality Improvement Scotland (NHS QIS )	A systematic narrative review of quality improvement models in health care
2009	HAYES, Inc.	Intravitreal bevacizumab (Avastin; Genentech Inc.) for the treatment of proliferative diabetic retinopathy
2009	Quality Improvement Scotland (NHS QIS )	Clinical and cost-effectiveness of self-monitoring of blood glucose (SMBG) for non-insulin treated type 2 diabetes
2009	VA Technology Assessment Program (VATAP)	Systematic reviews for localized prostate cancer
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Is biomedical research a good social investment? The evaluation of the social impact of medical research
2009	HAYES, Inc.	Breast-specific gamma imaging (BSGI)
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Multiple chemical hypersensibility: state of the art on aetiology and treatment
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®) for the treatment of HIV-1 infected, treatment-naïve adults in combination with other antiretroviral medicinal products
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	Amotosalen (Intercept) for the inactivation of pathogens in plasma and platelets: usage in Spain
2009	HAYES, Inc.	Laparoscopic ileal interposition and sleeve gastrectomy for treatment of type 2 diabetes [REVISED 02.16.09]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Degarelix (Firmagon®) for the treatment of advanced hormone-dependent prostate cancer
2009	HAYES, Inc.	Amyotrophic Lateral Sclerosis (ALS; Lou Gehrig Disease)
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Reprocessing of surgical drills
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Managing the difficult airway
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ranolazine (Ranexa®) as add-on therapy for symptomatic treatment of stable angina pectoris
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Emerging technologies (part 2): EU newsletter
2009	HAYES, Inc.	Laparoscopic sleeve gastrectomy for super obesity in adults
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Methoxy polyethylene glycol-epoetin beta (Mircera®)
2009	HAYES, Inc.	Breast cancer susceptibility 1 and 2 (BRCA1/2) sequence variant testing for susceptibility to hereditary breast cancer
2009	Agency for Healthcare Research and Quality (AHRQ)	Impact of consumer health informatics applications
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Mecasermin (Increlex®)
2009	Andalusian Health Technology Assessment Area (AETSA)	[Utility of PET-FDG to assess response of breast, oesophagus and lung neoplasms. A systematic review of results after neoadjuvant therapy]
2009	Agency for Healthcare Research and Quality (AHRQ)	Treatment of overactive bladder in women
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Information and communications technologies in mental health (Telepsychiatry)]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Filgrastim (Ratiograstim®) for the treatment of neutropenia
2009	NIHR Health Technology Assessment programme	Prostate trials office (PROTO): co-ordinating trials of new technologies in the treatment of BPH
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Physical disease in schizophrenia: systematic review and analysis of hospital records]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment of cerebrovascular disease]
2009	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and management of ductal carcinoma in situ (DCIS)
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Transient elastography (Fibroscan) for the diagnosis of liver fibrosis: a systematic review and meta-analysis]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Quetiapine prolonged-release tablets (Seroquel XL®) for the treatment of schizophrenia in adults
2009	HAYES, Inc.	AlloDerm regenerative tissue matrix (LifeCell Corp.) for postmastectomy breast reconstruction
2009	Agency for Healthcare Research and Quality (AHRQ)	Treatment of common hip fractures
2009	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[The effectiveness of Positron Emission Tomography (PET) with 18FDG in breast cancer. A systematic review and meta-analysis]
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Etravirine (Intelence®) for the treatment of HIV-1 infected, antiretroviral treatment-experienced adults in combination with a boosted protease inhibitor and other antiretroviral medicinal products
2009	HAYES, Inc.	COL1A1 and COL1A2 gene testing for osteogenesis imperfecta types I to IV
2009	HAYES, Inc.	Hippotherapy for Neuromusculoskeletal Dysfunction
2009	Agency for Healthcare Research and Quality (AHRQ)	Vitamin D and calcium: a systematic review of health outcomes
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Ropinirole prolonged-release (Requip XL®) for the treatment of idiopathic Parkinson's disease
2009	HAYES, Inc.	Continuous renal replacement therapy (CRRT) versus sustained low-efficiency daily dialysis (SLED) for adults with non-trauma-related acute renal failure
2009	Agency for Healthcare Research and Quality (AHRQ)	Outcomes of community health worker interventions
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Paricalcitol (Zemplar®) capsules for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency
2009	HAYES, Inc.	Liver transplantation for obese adults
2009	HAYES, Inc.	Continuous rotation of patients with acute respiratory distress syndrome (ARDS)
2009	Agency for Healthcare Research and Quality (AHRQ)	Outcomes of genetic testing in adults with a history of venous thromboembolism
2009	NIHR Health Technology Assessment programme	Erlotinib for the treatment of relapsed non-small cell lung cancer
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Micafungin (Mycamine®) for the treatment of invasive candidiasis in adults and children
2009	HAYES, Inc.	Continuous subglottic secretion removal from the Hi-Lo endotracheal tube (Nellcor Puritan Bennett LLC) for prevention of ventilator-associated pneumonia (VAP)
2009	Agency for Healthcare Research and Quality (AHRQ)	Clinical utility of cancer family history collection in primary care
2009	Agency for Healthcare Research and Quality (AHRQ)	Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force
2009	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Bivalirudin (Angiox®) for the treatment of adult patients with acute coronary syndromes planned for urgent or early intervention
2009	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy and safety of new oral antidiabetics. A systematic review of the literature and economic assessment]
2009	HAYES, Inc.	Impella recover LP 2.5 percutaneous ventricular assist device (Abiomed Inc.)
2009	Agency for Healthcare Research and Quality (AHRQ)	Complementary and alternative medicine in back pain utilization report